Agios Pharma (AGIO) Misses Q2 EPS by 4c

Agios Pharma (NASDAQ: AGIO) reported Q2 EPS of ($1.69), $0.04 worse than the analyst estimate of ($1.65). Revenue for the quarter came in at $44.74 million versus the consensus estimate of $26.57 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• GameStop CEO Cohen buys 1.15M shares
• Jefferies Starts United Overseas Bank Ltd. (UOB:SP) (UOVEY) at Buy
• CMS targets 15% Medicare lab fee cuts, putting DGX and LH revenue at risk